Your email has been successfully added to our mailing list.

×
0.000917225667101997 0.00324199118279838 0.00345333350240725 0.000811554507297711 -0.00035082825055048 -0.000139485930941759 0.00292497770338537 0.00155125262592831
Stock impact report

Lilly to not share early-stage data on COVID-19 antibody - Morgan Stanley [Seeking Alpha]

Morgan Stanley (MS) 
Last morgan stanley earnings: 4/16 07:15 am Check Earnings Report
US:NYSE Investor Relations: morganstanley.com/about-us-ir
Company Research Source: Seeking Alpha
In a note, Morgan Stanley's David Risinger says Eli Lilly (LLY-1.9%Phase 1 clinical trialLilly's decision appears to dash expectations of early release of data from an ongoing 400-subject Phase 2 trial,BLAZE-1The antibody wasidentified from a blood sampleShares are currently exchanging hands near session lows. Show less Read more
Impact Snapshot
Event Time:
MS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MS alerts
Opt-in for
MS alerts

from News Quantified
Opt-in for
MS alerts

from News Quantified